Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective.
Khushbu J PatelDavid YangHoward H FeldmanGing-Yuek Robin HsiungHaakon Berge NygaardJohn R BestEmily DwoshJulie M RobillardMari L DeMarcoPublished in: Alzheimer's & dementia (New York, N. Y.) (2024)
Perspectives of persons with lived experience in dementia provide new insight into the value of biomarker testing and should be included as part of evidence-guided considerations for pre-test counseling and result disclosure. Moreover, study findings identify an interval when patients and care partners are highly receptive to positive lifestyle and medical interventions.
Keyphrases
- healthcare
- end stage renal disease
- palliative care
- hiv testing
- physical activity
- chronic kidney disease
- newly diagnosed
- ejection fraction
- quality improvement
- mild cognitive impairment
- metabolic syndrome
- prognostic factors
- cardiovascular disease
- cognitive decline
- peritoneal dialysis
- case report
- pain management
- weight loss
- men who have sex with men
- smoking cessation
- hepatitis c virus
- patient reported